Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net loss	$ (877,917)	$ (1,004,251)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,132	4,459
Stock option compensation expense	7,180	16,069
Share-based compensation - common stock	$ 1,900	2,125
Common stock and warrants issued to consultants		182,600
Debt discount amortization	$ 144,665	49,720
Loss on conversion of notes		2,588
Changes in assets and liabilities:
Receivables	$ (41,246)	(1,072)
Prepaid expenses and other current assets	18,497	$ 73,466
Inventory	10,000
Accounts payable, accrued expenses and other liabilities	$ 208,919	$ 385,457
Deferred revenue		(5,905)
Net cash used in operating activities	$ (523,870)	(294,744)
Cash flows from financing activities:
Proceeds from notes payable	$ 600,000	257,000
Repayment of note and warrant settlement		(42,500)
Proceeds from common stock and warrants		75,000
Net cash provided by financing activities	$ 600,000	289,500
Net increase (decrease) in cash	76,130	(5,244)
Cash at beginning of period	49,801	5,742
Cash at end of period	$ 125,931	$ 501